Is there a role of Eastern Europe in cancer biomarkers for personalized cancer medicine?

被引:0
|
作者
Berindan-Neagoe, I. [1 ]
Paradiso, A. [2 ]
机构
[1] Univ Med & Pharm Iuliu Hatieganu, Cluj Napoca, Napoca, Romania
[2] IRCCS, Ist Tumori G Paolo 2, Natl Canc Res Ctr, Bari, Italy
关键词
D O I
10.3233/CBM-130342
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:85 / 86
页数:2
相关论文
共 50 条
  • [1] Colon Cancer Biomarkers: Implications for Personalized Medicine
    Pritzker, Kenneth P. H.
    JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (04):
  • [2] Biomarkers in Ovarian Cancer: Towards Personalized Medicine
    Lopez-Portugues, Carlos
    Montes-Bayon, Maria
    Diez, Paula
    PROTEOMES, 2024, 12 (01)
  • [3] Predictive biomarkers for personalized medicine in breast cancer
    Rodrigues-Ferreira, Sylvie
    Nahmias, Clara
    CANCER LETTERS, 2022, 545
  • [4] Emerging Biomarkers in the Era of Personalized Cancer Medicine
    Ricciuti, Biagio
    Leonardi, Giulia C.
    Brambilla, Marta
    DISEASE MARKERS, 2019, 2019
  • [5] Colorectal Cancer Biomarkers in the Era of Personalized Medicine
    Patel, Jai N.
    Fong, Mei Ka
    Jagosky, Megan
    JOURNAL OF PERSONALIZED MEDICINE, 2019, 9 (01):
  • [6] microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers
    Saumet, Anne
    Lecellier, Charles-Henri
    MICRORNA: MEDICAL EVIDENCE: FROM MOLECULAR BIOLOGY TO CLINICAL PRACTICE, 2015, 888 : 5 - 15
  • [7] The role of biomarkers to guide personalized cancer care
    Pai, Sara
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 100 - 100
  • [8] Role of nanobiotechnology in developing personalized medicine for cancer
    Jain, KK
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2005, 4 (06) : 645 - 650
  • [9] Lung Cancer Therapy: The Role of Personalized Medicine
    Ramos, Raquel
    Moura, Conceicao Souto
    Costa, Mariana
    Lamas, Nuno Jorge
    Correia, Renato
    Garcez, Diogo
    Pereira, Jose Miguel
    Lindahl, Thomas
    Sousa, Carlos
    Vale, Nuno
    CANCERS, 2025, 17 (05)
  • [10] Predictive biomarkers: a paradigm shift towards personalized cancer medicine
    Nicholas B. La Thangue
    David J. Kerr
    Nature Reviews Clinical Oncology, 2011, 8 : 587 - 596